Global Respiratory Syncytial Virus (RSV) Diagnostics market size is expected to reach $1.84 billion by 2030 at 10.4%, impact of rising respiratory disease prevalence on diagnostic demand
Read MoreGlobal Meningococcal Disease Vaccine market size is expected to reach $4.11 by 2030 at 9.6%, government immunization programs fueling the growth of the market due to increasing access awareness and mandates
Read MoreThe primary antibody market will reach $68.27 by 2030 at 8.3% CAGR, driven by biomarker research, rising biotech investment, and advances in antibody engineering and assays.
Read MoreGlobal Respiratory Disease Testing market size is expected to reach $4.93 billion by 2030 at 5.8%, surging prevalence of respiratory diseases sparks growth in the respiratory disease testing market
Read MoreGlobal Resorbable Vascular Scaffolds market size is expected to reach $0.92 billion by 2030 at 12.3%, rising prevalence of cardiovascular diseases boosts advanced treatment solutions
Read MorePreventive Healthcare Technologies And Services market size is expected to reach $694.9 billion by 2030 at 15.1%, driven by increasing demand for hospitals.
Read MoreThe melatonin market is projected to reach $2.99 billion by 2030, growing at 7.9% CAGR, driven by personalized sleep solutions, natural supplements, and mental wellness focus.
Read MoreGlobal Resistance Bands market size is expected to reach $3 billion by 2030 at 12.5%, segmented as by tube resistance bands, single tube bands, double tube bands, triple tube bands
Read MorePreterm Birth Prevention And Management market size is expected to reach $2.86 billion by 2030 at 7.3%, driven by increasing awareness of maternal and fetal health.
Read MoreResidential substance abuse and mental health facilities market to reach $154.85 billion by 2030 at 7.0% cagr, driven by rising healthcare expenditures.
Read More